Abstract:Background: In recent years, tissue engineered bone by gene-modified stem cells compounded with scaffold materials in repair of bone defect has provided a novel thought for the bone tissue reconstruction. Objective: To explore the effect on repairing mandibular defect with human bone morphogenetic protein-2 (hBMP-2) gene transfected bone marrow mesenchymal stem cells (BMSCs) compounded with coral hydroxyapatite (CHA) scaffolds in osteoporotic rats. Design, time and setting: A randomized control animal experiment was completed at the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education from June 2005 to October 2006. Materials: Twenty-four unpregnant female Sprague-Dawley rats, 6 months old, SPF gradem weighing 250-300 g, were used to establish models of postmenopausal osteoporosis, The pcDNA3.1-hBMP-2 recombinant plasmid carrying hBMP-2 was offered by the Third Military Medical University of Chinese PLA; CHA scaffolds was offered by the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education. Methods: Twenty-four SD rats were divided into experimental group and control group at random, each containing 12 animals. Three months later, BMSCs harvested from osteoporotic rats were transfected by pcDNA3.1-hBMP-2 recombinant plasmid, and control group leaved untreated. Three days later, the transfected and untransfected autogenous BMSCs were seeded into CHA scaffolds, respectively. Then the cell/scaffolds composites were implanted into the critical-size defect area in the mandible bone of osteoporotic rats. Main outcome measures: At the 4th and 8th weeks after implantation, immunohistochemical analysis was performed to evaluate the new bone formation, and the amount of newly formed bone was detected semi-quantitatively at the 8th weeks. Results: All 24 SD rats were involved in the result analysis. 1 Newly formed bone was found at the margin of the defect area treated with the BMSCs modified by BMP-2 gene transfer at 4 weeks after implantation. The lamellar bone matrix was visible at 8 weeks. In the control group, only a little bone matrix was observed at the margin of CHA material at 4 weeks after implantation, however, the amount of newly formed bone was much less than the experimental group, and there was some adipose-like tissues at defect margins and central part at 8 weeks after implantation. 2 The percentage of newly formed bone area was (0.046±0.004)% and (0.233±0.015)% in the control group and the experimental group, respectively. There were significant differences in the amount of newly formed bone between two groups (P < 0.01). Conclusion: Tissue engineered bone formed by hBMP-2 gene-modified BMSCs in conjunction with CHA scaffolds, can allow large bone formation for treatment of mandibular defect in osteoporosis rats.

Cementum protein 1 gene-modified adipose-derived mesenchymal stem cell sheets enhance periodontal regeneration in osteoporosis rat

Potential of an Aligned Porous Hydrogel Scaffold Combined with Periodontal Ligament Stem Cells or Gingival Mesenchymal Stem Cells to Promote Tissue Regeneration in Rat Periodontal Defects

Regeneration Potential of Decellularized Periodontal Ligament Cell Sheets Combined with 15-Deoxy-δ12,14-prostaglandin J2 Nanoparticles in a Rat Periodontal Defect

Regeneration of rat periodontium by cementum protein 1-derived peptide

Leptin Overexpression in Bone Marrow Stromal Cells Promotes Periodontal Regeneration in a Rat Model of Osteoporosis

Controlled release of recombinant human cementum protein 1 from electrospun multiphasic scaffold for cementum regeneration.

Adipose-derived Stem Cell Sheets Combined with Β-Tricalcium Phosphate/collagen-I Fiber Scaffold Improve Cell Osteogenesis.

OPG gene-modified adipose-derived stem cells improve bone formation around implants in osteoporotic rat maxillae

[Human Osteoprotegerin Inhibits Osteoclasts and Promotes Hydroxyapatite to Repair the Mandibular Defects in Ovariectomized Rats].

Repairing mandibular defect by gene-modified bone marrow mesenchymal stem cells combined with coral hydroxyapatite scaffold in osteoporotic rats

Combination adipose-derived mesenchymal stem cells-demineralized dentin matrix increase bone marker expression in periodontitis rats

Metformin-loaded β-TCP/CTS/SBA-15 composite scaffolds promote alveolar bone regeneration in a rat model of periodontitis

[Effect of the compound of poly lactic-co-glycolic acid and bone marrow stromal cells modified by osteoprotegerin gene on the periodontal regeneration in Beagle dog periodontal defects]

Clumps of mesenchymal stem cells/extracellular matrix complexes directly reconstruct the functional periodontal tissue in a rat periodontal defect model

Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells

hVEGF Gene Modified Tissue-engineered Compound in the Reconstruction of Periodontal Tissue Defects in SD Rats

Osteoprotegerin gene-modified BMSCs with hydroxyapatite scaffold for treating critical-sized mandibular defects in ovariectomized osteoporotic rats

Injectable periodontal ligament stem cell-metformin-calcium phosphate scaffold for bone regeneration and vascularization in rats

hBMP-7 Gene Modified Bone Marrow Stromal Cells on the Effects of Healing of Periodontal Furcation Defects in Osteoporosis Rats

Bone Marrow Mesenchymal Stem Cell Sheets with High Expression of Hbd3 and CTGF Promote Periodontal Regeneration.

Estrogen Enhances The Bone Regeneration Potential Of Periodontal Ligament Stem Cells Derived From Osteoporotic Rats And Seeded On Nano-Hydroxyapatite/Collagen/Poly(L-Lactide)